Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs General Motors Company (GM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs General Motors Company — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $69 (market cap $30.93B), while General Motors Company trades at $83.71 (market cap $72.87B). The key difference: General Motors Company is far larger — about 2.4× GE HealthCare Technologies Inc. Common Stock's market cap, and General Motors Company pays the higher dividend (0.87%). Which is the better fit depends on your goals.
| GEHC | GM | |
|---|---|---|
Market Cap | $30.93B | $72.87B |
Volume | 5,033,451 | 6,101,486 |
Sector | Health | Consumer Cyclical |
52-Week High | $88.16 | $90.30 |
52-Week Low | $59.48 | $57.34 |
Enterprise Value | $39.39B | $175.85B |
Dividend Yield | 0.23% | 0.87% |
Typical Hold Time | — | 83 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
General Motors (GM) trades at $84.00, up 1.98% today, with a bullish technical signal from moving averages. The company has beaten earnings estimates for three consecutive quarters, though revenue declined slightly in 2025. Analyst consensus is strongly positive with a $102.33 price target, but recent news highlights competitive pressures and a 5.5% drop in Q3 2026 U.S. vehicle sales.
GM faces headwinds from declining market share and weak electric vehicle demand, but cost savings from eased fuel economy rules and consistent earnings beats provide upside potential. Key risks include high debt levels and intense competition. The stock appears fundamentally undervalued on P/S and P/B metrics relative to analyst targets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About General Motors Company
General Motors Co. emerged from the bankruptcy of General Motors Corp. (old GM) in July 2009. GM has eight brands and operates under four segments: GM North America, GM International, Cruise, and GM Financial. The United States now has four brands instead of eight under old GM. The company lost its U.S. market share leader crown in 2021 with share down 280 basis points to 14.6%, but we expect GM to reclaim the top spot in 2022 as 2021 suffered from the chip shortage. GM Financial became the company's captive finance arm in October 2010 via the purchase of AmeriCredit.
Read more on GM →
